Article: Mitsubishi Pharma entered into a one-year site license agreement for Safe-Hit.(Microarrays: sales/orders of note)(Brief Article)

Mitsubishi Pharma entered into a one-year site license agreement for Safe-Hit, a microarray-based system developed by drug discovery company ExonHit ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!